drugset / Trial / NCT01917695

Study on Early Stage Bulky Cervical Cancers

NCT01917695 ↗

Phase 3 Unknown 180 enrolled Rajkumar Kottayasamy Seenivasagam
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to establish the role of neoadjuvant chemotherapy and chemo irradiation in carcinoma cervix and to compare its results with the concurrent chemo irradiation in terms of overall survival, disease free survival and quality of life.

Timeline

Start
2013-08
Primary completion
2018-08
Completion
2018-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 75 mg/m2 —
Subject Paclitaxel Small molecule 175 mg/m2 —

Indications